Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.62 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.62 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.62 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.62 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.62 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.61 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.58 |
| ▸ | PPARG | P37231 | 7/20 | 0.58 |
| ▸ | PPARD | Q03181 | 7/20 | 0.58 |
| ▸ | PPARA | Q07869 | 7/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.58 |
| ▸ | TSHR | P16473 | 4/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TLR2 | O60603 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | FABP4 | P15090 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.58 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL8569599 | 0.98 | FFAR3 (0.65) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL7629511 | 0.93 | FFAR3 (0.72) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL21810531 | 0.91 | FFAR3 (0.62) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL315107 | 0.90 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL608115 | 0.90 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL4783360 | 0.90 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Hexanoate SCHEMBL28837892 | 0.88 | AKR1B1 (0.80) | AKR1B1GPR84PPARGPPARDPPARA | |
| Butyric Acid SCHEMBL8837397 | 0.88 | FFAR3 (0.65) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL2676630 | 0.87 | FFAR3 (0.72) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Heptane SCHEMBL8097495 | 0.87 | GPR84 (0.75) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2310315-A2 | FILM AND DEVICE USING LAYER BASED ON RIBTAN MATERIAL | Carben Semicon Limited (CY) | 2011-04-20 | — | — | EP | disclosed |
| EP-2311078-A1 | PATTERNED INTEGRATED CIRCUIT AND METHOD OF PRODUCTION THEREOF | Carben Semicon Limited (CY) | 2011-04-20 | — | — | EP | disclosed |
| EP-2311113-A2 | INTEGRATED CIRCUIT WITH RIBTAN INTERCONNECTS | Carben Semicon Limited (CY) | 2011-04-20 | — | — | EP | disclosed |
| US-20110064892-A1 | Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base | CRYSOPTIX KK | 2011-03-17 | — | — | US | disclosed |
| US-20100224998-A1 | Integrated Circuit with Ribtan Interconnects | CARBEN SEMICON LIMITED (CY) | 2010-09-09 | — | — | US | disclosed |
| US-20100173134-A1 | Film and Device Using Layer Based on Ribtan Material | CARBEN SEMICON LIMITED (CY) | 2010-07-08 | — | — | US | disclosed |
| WO-2009158551-A2 | INTEGRATED CIRCUIT WITH RIBTAN INTERCONNECTS | CARBEN SEMICON LIMITED (CY) | 2009-12-30 | — | — | WO | disclosed |
| WO-2009158553-A2 | FILM AND DEVICE USING LAYER BASED ON RIBTAN MATERIAL | CARBEN SEMICON LIMITED (CY) | 2009-12-30 | — | — | WO | disclosed |
| WO-2009158552-A1 | PATTERNED INTEGRATED CIRCUIT AND METHOD OF PRODUCTION THEREOF | CARBEN SEMICON LIMITED (CY) | 2009-12-30 | — | — | WO | disclosed |
| EP-0501206-B1 | Phenone compounds, process for their preparation and their pharmaceutical preparations | PLANTAMED ARZNEIMITTEL GMBH (DE) | 1996-08-28 | — | — | EP | disclosed |
| EP-0501206-A2 | Phenone compounds, process for their preparation and their pharmaceutical preparations | Plantamed Arzneimittel GmbH (DE) | 1992-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100173134-A1 | Film and Device Using Layer Based on Ribtan Material | RNF213, PRDM9, RNF10 | FFAR3 4674/4885HDAC3 4841/4885HDAC1 4877/4885 |
| US-20110064892-A1 | Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base | MCM3, CCNA2, CCNB2 | FFAR3 4390/4885HDAC3 2079/4885HDAC1 2566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.